Addressing Clinician-Reported Barriers Improves Confidence in PrEP Prescribing
Clinician-reported barriers to PrEP prescribing include finances, perceptions about HIV risk, lack of training, and the amount of time required for PrEP care.
Read More
HIV PrEP
Steep Increase in Event-Driven PrEP Use
Researchers found a steep increase in even-driven PrEP use among cisgender gay, bisexual, and other men who have sex with men.
Read More
Considerable Scale-Up Needed to Meet 2025 HIV PrEP Goals
About 3.5 million persons used PrEP in 2023 globally, which was far below the goal of 21.2 million set for 2025.
Read More
ICI Therapy Does Not Increase Mortality Risk in Patients With Pre-Existing Autoimmune Disease
The mortality risk in patients with pre-existing auto-immune disease is not significantly different from those without AIDS, in an immune checkpoint inhibitor study.
Read More
Q&A: Addressing Barriers to Long-Acting Injectable PrEP for Transgender Women
Research shows many transgender women in the U.S. express interest in long-acting injectable PrEP but face barriers to accessing preventive treatment.
Read More
Perceived HIV Risk Low Among People Who Inject Drugs
In general, many people who inject drugs perceive themselves to be at a low risk for HIV despite having indications for pre-exposure prophylaxis use.
Read More
PrEP Use Increased From 2013 to 2023
The annual number of PrEP users increased in the United States from 10,281 in 2013 to 505,730 in 2023, primarily in oral formulations.
Read More
Addressing Stigma Alone May Not Improve PrEP Use in Black MSM
In a study of PrEP use in Black sexual minority men, PrEP stigma was associated with a lower likelihood of current PrEP use in all models examined.
Read More
Q&A: Improving PrEP Access in Transgender Men, Other Transmasculine People
Researchers discuss efforts to improve PrEP access in transgender and other transmasculine men who are under-represented in research and prevention efforts.
Read More
PrEP Program Reduces New HIV & Gonorrhea Infections
A PrEP program that included medication distribution and counseling could reduce thousands of new cases of HIV and gonorrhea and showed potential for scaling.
Read More
Multiple Factors Influence PrEP Efficacy in Transgender Men
Testosterone, Lactobacillus, and lower PrEP medication concentrations in cervicovaginal fluid may impact HIV risk in transgender men.
Read More
Screening for Intimate Partner Violence Represents New Strategy to Increase PrEP Uptake
A recent literature review highlighted “complex intersections” between intimate partner violence and PrEP care engagement among sexual minority men.
Read More
HIV Risk Underestimated By Those on Parole
People on parole or under community supervision experience discrepancies between perceived and actual risk for HIV.
Read More
Clinical Requirements & Personal Factors Impact PrEP Uptake
In the United States, potential PrEP users and current PrEP users both reported issues related to medication as barriers to uptake.
Read More
Point-of-Care Urine Testing Predicts PrEP Discontinuation
A novel point-of-care urine test for PrEP drug levels predicted PrEP discontinuation in young people more accurately than self-reported PrEP adherence.
Read More
Telehealth-Based PrEP Ups Knowledge, Awareness in Latina Women
Information sessions raise awareness and knowledge of PrEP use among Latina women.
Read More
Point-of-Care Treatment Predicts Future PrEP Discontinuation
Point-of-care urine tenofovir rapid assay testing predicted pre-exposure prophylaxis (PrEP) discontinuation among young men who have sex with men and transgender women more accurately than self-reported adherence.
Read More
Bi-Yearly PrEP Monitoring Safe, Effective, and Associated With Lower Costs
Findings suggest implementing 6-monthly PrEP monitoring may cut visits without raising STI...
Read More